89 results on '"El Hasbani G"'
Search Results
2. The impact of nicotine smoking on spondyloarthritis and rheumatoid arthritis.
- Author
-
El Hasbani, G., E Nassar, J., Elsayed Ali, A.M., Uthman, I., and Jawad, A.
- Published
- 2024
- Full Text
- View/download PDF
3. Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma
- Author
-
El Hasbani, G., primary, Del Pilar Morel, M., additional, Tandoh, B., additional, Vargas, J.F., additional, and Crusio, R., additional
- Published
- 2023
- Full Text
- View/download PDF
4. When Tophaceous Gout Involves Multiple Organs: Challenges and Solutions
- Author
-
El Hasbani, G, primary
- Published
- 2023
- Full Text
- View/download PDF
5. Rheumatology research output in the Arab World: despite the challenges
- Author
-
El Hasbani, G., primary, Jawad, A.S.M., additional, and Uthman, I., additional
- Published
- 2022
- Full Text
- View/download PDF
6. This title is unavailable for guests, please login to see more information.
- Author
-
Taher, A.T. Cappellini, M.D. Kattamis, A. Voskaridou, E. Perrotta, S. Piga, A.G. Filosa, A. Porter, J.B. Coates, T.D. Forni, G.L. Thompson, A.A. Tartaglione, I. Musallam, K.M. Backstrom, J.T. Esposito, O. Giuseppi, A.C. Kuo, W.-L. Miteva, D. Lord-Bessen, J. Yucel, A. Zinger, T. Shetty, J.K. Viprakasit, V. Buaboonnam, J. Ekwattanakit, S. Khunhapinant, A. Loka, E. Moraki, M. Flevari, P. Dimopoulou, M. Bartzi, V. Daadaa, H. El Hasbani, G. Koussa, S. Ammendola, F. Scianguetta, S. Puglia, M. Ferrara, I. Ferrero, G. Gaglioti, C. Longo, F. Turrini, S. Voi, V. Cassinerio, E. De, A. Graziadei, G. Marcon, A. Migone De Amicis, M. Motta, I. Cinque, P. Pannone, B. Ricchi, P. Balocco, M. Carrara, P. Della Rovere, F. Lamagna, M. Pinto, V. Quintino, S. Eleftheriou, P. Garbowski, M. de Kreuk, A. Carson, S. Denton, C. Hofstra, T. Veluswamy, S. Wood, J. Badawy, S. Bercovitz, R. Bhat, R. Calamaras, D. Liem, R. Mack, A. BEYOND Investigators and Taher, A.T. Cappellini, M.D. Kattamis, A. Voskaridou, E. Perrotta, S. Piga, A.G. Filosa, A. Porter, J.B. Coates, T.D. Forni, G.L. Thompson, A.A. Tartaglione, I. Musallam, K.M. Backstrom, J.T. Esposito, O. Giuseppi, A.C. Kuo, W.-L. Miteva, D. Lord-Bessen, J. Yucel, A. Zinger, T. Shetty, J.K. Viprakasit, V. Buaboonnam, J. Ekwattanakit, S. Khunhapinant, A. Loka, E. Moraki, M. Flevari, P. Dimopoulou, M. Bartzi, V. Daadaa, H. El Hasbani, G. Koussa, S. Ammendola, F. Scianguetta, S. Puglia, M. Ferrara, I. Ferrero, G. Gaglioti, C. Longo, F. Turrini, S. Voi, V. Cassinerio, E. De, A. Graziadei, G. Marcon, A. Migone De Amicis, M. Motta, I. Cinque, P. Pannone, B. Ricchi, P. Balocco, M. Carrara, P. Della Rovere, F. Lamagna, M. Pinto, V. Quintino, S. Eleftheriou, P. Garbowski, M. de Kreuk, A. Carson, S. Denton, C. Hofstra, T. Veluswamy, S. Wood, J. Badawy, S. Bercovitz, R. Bhat, R. Calamaras, D. Liem, R. Mack, A. BEYOND Investigators
- Published
- 2022
7. Quality of life measures in Systemic Lupus Erythematosus: A systematic review
- Author
-
Radin, M., primary, El Hasbani, G., additional, Barinotti, A., additional, Roccatello, D., additional, Uthman, I., additional, Taher, A., additional, and Sciascia, S., additional
- Published
- 2022
- Full Text
- View/download PDF
8. Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases
- Author
-
El Hasbani, G., primary, Jawad, A., additional, and Uthman, I., additional
- Published
- 2021
- Full Text
- View/download PDF
9. Quality of life measures in Systemic Lupus Erythematosus: A systematic review.
- Author
-
Radin, M., El Hasbani, G., Barinotti, A., Roccatello, D., Uthman, I., Taher, A., and Sciascia, S.
- Published
- 2021
- Full Text
- View/download PDF
10. Antiphospholipid syndrome and infertility
- Author
-
El Hasbani, G, primary, Khamashta, M, additional, and Uthman, I, additional
- Published
- 2019
- Full Text
- View/download PDF
11. Neutrophil Extracellular Traps are Present in Immune-complex-mediated Cutaneous Small Vessel Vasculitis and Correlate with the Production of Reactive Oxygen Species and the Severity of Vessel Damage
- Author
-
Bergqvist, C, primary, Safi, R, additional, El Hasbani, G, additional, Abbas, O, additional, Kibbi, A, additional, and Nassar, D, additional
- Published
- 2019
- Full Text
- View/download PDF
12. Antiphospholipid syndrome and infertility.
- Author
-
El Hasbani, G, Khamashta, M, and Uthman, I
- Subjects
- *
ANTIPHOSPHOLIPID syndrome , *PHOSPHOLIPID antibodies , *INFERTILITY , *MALE infertility , *AUTOIMMUNE diseases - Abstract
Antiphospholipid syndrome is a systemic autoimmune disease associated with obstetric complications along with vascular events affecting multiple organ systems in patients having positive titers of antiphospholipid antibodies. Eight to 20% of infertility cases have an unknown cause, part of which could be due to antiphospholipid syndrome. Although still debatable, many studies have addressed the relation between reproductive failure and antiphospholipid antibodies through the relation between antiphospholipid antibodies and unexplained infertility as well as the effect of antiphospholipid antibodies on the outcome of in vitro fertilization–embryo transfer. Few studies and cases have associated the presence of antiphospholipid antibodies with male infertility, describing morphofunctional penile abnormalities and testicular infarction. There are not enough data to support the routine practice of testing antiphospholipid antibodies in patients with infertility. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Effect of coconut oil in the post-weaning starter diet on growth and carcass qualities of male lambs, weaned early and intensively fattened in winter
- Author
-
Bozzolo, G., primary, Bouillier-Oudot, M., additional, Candau, M., additional, El Hasbani, G., additional, Grasset, D., additional, and Manse, H., additional
- Published
- 1993
- Full Text
- View/download PDF
14. Clinical Images: Temporalis muscle and temporal bone metastasis: giant cell arteritis mimicker.
- Author
-
El Hasbani G, Stern JI, Sener U, Thangaiah JJ, and Warrington KJ
- Published
- 2025
- Full Text
- View/download PDF
15. Urinary Retention as an Initial Clinical Manifestation of Primary Sjögren's Syndrome.
- Author
-
Sleem B, Ghazi V, El Hasbani G, and Uthman I
- Abstract
Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease known to affect exocrine glands, leading to symptoms such as dry eyes and mouth. However, pSS can manifest in other systems, including rare genitourinary presentations. Urinary retention, although unusual, has been associated with pSS throughout the disease, particularly when related to neurogenic bladder dysfunction. However, it is unusual for neurogenic bladder dysfunction to be the initial presentation of pSS. We present the case of a 38-year-old woman who initially presented with unexplained urinary retention, followed by the development of systemic symptoms such as hand arthritis, morning stiffness, photosensitivity, and dry eyes. As Shirmer's test was positive and anti-SSA was strongly positive, she was diagnosed with pSS. Treatment with hydroxychloroquine alleviated both her systemic symptoms and urinary retention., Competing Interests: Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work., (Copyright © 2024, Sleem et al.)
- Published
- 2024
- Full Text
- View/download PDF
16. A Case of Eosinophilic Fasciitis.
- Author
-
El Hasbani G, Tarhini A, Jawad AS, and Uthman I
- Published
- 2024
- Full Text
- View/download PDF
17. The Impact of Tobacco Smoking on Systemic Sclerosis, Idiopathic Inflammatory Myositis, and Systemic Lupus Erythematosus.
- Author
-
El Hasbani G, Madi M, Zoghbi MASE, Srour L, Uthman I, and Jawad AS
- Abstract
This narrative review aims specifically to explore the relationship between tobacco exposure and systemic sclerosis (SSc), idiopathic inflammatory myositis (IIM), and systemic lupus erythematosus (SLE). Relevant articles were obtained by searching key terms such as "tobacco," "smoking," "scleroderma," "myositis," "lupus," and "Sjögren's" in PubMed and Google Scholar databases. The selected articles ranged from the years 2010 to 2023. Inclusion criteria were based on the relevance and contribution to the field of study. Systemic sclerosis is a complex condition involving multiple immune cell lines that can be influenced by tobacco. However, the existing literature does not provide sufficient evidence to support an increased risk of SSc in smokers or the impact on treatment options. Cigarette smoking does increase the risk of skin ulcerations in SSc patients. In addition, cigarette smoking has been associated with IIM through genetic and molecular mechanisms. Smokers with dermatomyositis or polymyositis are at an elevated risk of atherosclerosis and interstitial lung disease. Similarly, smoking in patients with SLE increases the risk of organ damage, thrombosis, and disease severity compared with non-smokers. Smokers with SLE also have more difficulty in controlling disease flares compared with non-smokers. Tobacco exposure can lead to secondary complications in patients with IIM and SLE, although the course of treatment may not differ significantly. No definitive conclusions can be drawn to the clear relationship between tobacco smoking and Sjögren's's syndrome., Competing Interests: The authors declare that there is no conflict of interest., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
18. Acquired Madelung's deformity as a cause of recurrent monoarthritis in a young patient.
- Author
-
El Hasbani G, Jawad A, and Uthman I
- Abstract
Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
19. Ant colony optimization for the identification of dysregulated gene subnetworks from expression data.
- Author
-
Hanna EM, El Hasbani G, and Azar D
- Subjects
- Humans, Algorithms, Neurodegenerative Diseases genetics, Gene Expression Profiling methods, Computational Biology methods, Animals, Ants genetics, Databases, Genetic, Gene Regulatory Networks genetics
- Abstract
Background: High-throughput experimental technologies can provide deeper insights into pathway perturbations in biomedical studies. Accordingly, their usage is central to the identification of molecular targets and the subsequent development of suitable treatments for various diseases. Classical interpretations of generated data, such as differential gene expression and pathway analyses, disregard interconnections between studied genes when looking for gene-disease associations. Given that these interconnections are central to cellular processes, there has been a recent interest in incorporating them in such studies. The latter allows the detection of gene modules that underlie complex phenotypes in gene interaction networks. Existing methods either impose radius-based restrictions or freely grow modules at the expense of a statistical bias towards large modules. We propose a heuristic method, inspired by Ant Colony Optimization, to apply gene-level scoring and module identification with distance-based search constraints and penalties, rather than radius-based constraints., Results: We test and compare our results to other approaches using three datasets of different neurodegenerative diseases, namely Alzheimer's, Parkinson's, and Huntington's, over three independent experiments. We report the outcomes of enrichment analyses and concordance of gene-level scores for each disease. Results indicate that the proposed approach generally shows superior stability in comparison to existing methods. It produces stable and meaningful enrichment results in all three datasets which have different case to control proportions and sample sizes., Conclusion: The presented network-based gene expression analysis approach successfully identifies dysregulated gene modules associated with a certain disease. Using a heuristic based on Ant Colony Optimization, we perform a distance-based search with no radius constraints. Experimental results support the effectiveness and stability of our method in prioritizing modules of high relevance. Our tool is publicly available at github.com/GhadiElHasbani/ACOxGS.git., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
20. Idiopathic Granulomatous Mastitis, Erythema Nodosum, and Polyarthritis.
- Author
-
Tarhini A, El Hasbani G, Farhat L, Ghieh D, and Uthman I
- Abstract
Idiopathic granulomatous mastitis (IGM) is an inflammatory-mediated rare disease that can be linked to rare manifestations. Erythema nodosum (EN) and polyarthritis, seen in a multitude of autoinflammatory and autoimmune diseases, have been rarely linked to IGM. Despite the cause of IGM being unclear, Corynebacterium infections are thought to play a role in the pathophysiology of IGM. Unusually, IGM has a relapsing and remitting course, which also applies to its systemic manifestations. As such, we present a case of IGM in a middle-aged lady who was initially thought to have Corynebacterium-containing unilateral abscesses for which drainage was performed. However, several abscesses devoid of bacterial growth started recurring, and the disease course was complicated by EN and polyarthritis. IGM, EN, and polyarthritis eventually resolved and were managed with symptomatic treatment., Competing Interests: The authors declare that there is no conflict of interest., (© The Author(s) 2024.)
- Published
- 2024
- Full Text
- View/download PDF
21. An update on the endocrine manifestations of antiphospholipid syndrome.
- Author
-
El Hasbani G and Uthman I
- Subjects
- Humans, Female, Male, Pregnancy, Risk Factors, Prognosis, Pregnancy Complications etiology, Pregnancy Complications diagnosis, Endocrine System Diseases diagnosis, Endocrine System Diseases etiology, Pancreatic Diseases etiology, Pancreatic Diseases diagnosis, Antiphospholipid Syndrome diagnosis, Antiphospholipid Syndrome complications, Antiphospholipid Syndrome immunology
- Abstract
Antiphospholipid Syndrome (APS), characterized by hypercoagulability and pregnancy morbidity, poses a significant clinical challenge when involving organ systems, such as the endocrine system. APS can directly and indirectly influence the anterior and posterior lobes of the pituitary gland. The thyroid gland exhibits involvement, especially in patients with positive anticardiolipin antibodies, yet the clinical significance of the relationship with APS remains elusive. The pancreas, often overlooked, manifests in diverse ways, from pancreatitis to implications in diabetes. Adrenal insufficiency emerges as a common endocrine manifestation of APS, with adrenal hemorrhage or infarction being a presenting manifestation. Adrenal gland involvement has also been reported in the context of catastrophic APS. Pregnancy complications and infertility might be effects of APS on the female ovaries, while testicular torsion and decreased sperm concentration and total sperm count have been reported as rare effects of APS on male testes., (© 2024 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
22. Adult-Onset Still's Disease Following COVID-19 Infection in a Patient Receiving Nirmatrelvir/Ritonavir: A Case Report.
- Author
-
El Hasbani G, Applewhite AI, Scheuing W, and Maher L
- Abstract
SARS-CoV-2 (COVID-19) has been associated with numerous complications, including autoimmune and autoinflammatory diseases. The surge of cytokines following COVID-19 infection or vaccination has been proposed to contribute to immune dysregulation, which might subsequently give rise to an autoinflammatory syndrome. Adult-onset Still's disease (AOSD) is one of the rare autoinflammatory diseases characterized by a surge of cytokines. Although an association between COVID-19 vaccines and AOSD has been reported, an association with COVID-19 infection or nirmatrelvir/ritonavir remains very rare. In this case, we present a patient who developed AOSD after COVID-19 infection and subsequent treatment with nirmatrelvir/ritonavir. After the initial response to glucocorticoids, canakinumab was initiated, resulting in positive clinical outcomes., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, El Hasbani et al.)
- Published
- 2024
- Full Text
- View/download PDF
23. Maxillary Sinusitis with Aspergillus Infection Mimicking Giant Cell Arteritis.
- Author
-
El Hasbani G, Li ZY, and Cunha JS
- Published
- 2024
- Full Text
- View/download PDF
24. Sarcoidosis as a cause of chronic back pain: a case report.
- Author
-
El Hasbani G, Nicolas J, Najjar V, Jawad A, and Uthman I
- Abstract
While sarcoidosis is typically a multisystem disease, it can, in some instances, exclusively affect the vertebrae, leading to back pain. Additionally, sarcoidosis may manifest with inflammation of the sacroiliac joints, not meeting the criteria for spondyloarthritis, yet contributing to back pain. In this report, we present a case involving a previously healthy 55-year-old woman who sought medical attention due to chronic back pain. She was subsequently diagnosed with spinal sarcoidosis, based on MRI, PET scan, and biopsy results. Furthermore, treatment with prednisolone monotherapy demonstrated substantial improvement in her symptoms.
- Published
- 2024
- Full Text
- View/download PDF
25. Refractory Adult-onset Still's Disease Treated with a Combination of Methotrexate and Etanercept.
- Author
-
El Hasbani G, Ahmad Y, and Cassetta M
- Subjects
- Adult, Humans, Etanercept therapeutic use, Drug Therapy, Combination, Glucocorticoids therapeutic use, Methotrexate therapeutic use, Still's Disease, Adult-Onset drug therapy
- Abstract
Background: Adult-onset Still's disease (AOSD) is a challenging diagnosis because of the variability in clinical presentation and lack of gold-standard diagnostic investigations. Even after diagnosis, the treatment is challenging, especially when the disease is refractory to first-line therapy. Multiple pharmacotherapeutic options exist for refractory AOSD, but treatment failures still occur. Etanercept, a Tumor necrosis factor (TNF)-alpha inhibitor, is one of the options that has been rarely used for refractory AOSD, with various outcomes ranging from no response to complete remission., Case Presentation: In this case, we highlight how a previously healthy lady had refractory AOSD to glucocorticoids, methotrexate, and hydroxychloroquine combination therapy. There was no response to interleukin (IL)-1 therapy, which necessitated a switch to a combination of etanercept, low-dose methotrexate, and low-dose glucocorticoids with complete remission for a total of three- -year follow-up., Conclusion: The combination of methotrexate and Etanercept can maintain remission in patients with refractory AOSD., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2024
- Full Text
- View/download PDF
26. Vacuolar Interface Dermatitis as a Histologic Reaction Pattern of Sjögren's Syndrome: A Case Report.
- Author
-
El Hasbani G, Kibbi AG, Jawad A, and Uthman I
- Abstract
Sjögren's syndrome (SS) has been widely known for its dry mouth and dry eyes presentation. Extraglandular disease manifestations may be protean and pose a challenge for clinicians, especially when the typical known manifestations are absent. Skin involvement of SS is variable, and cutaneous signs and symptoms may be the initial presentation of this syndrome. Vacuolar interface dermatitis has been linked to dermatomyositis and systemic lupus erythematosus, but rarely to SS. Herein, we present the case of an 87-year-old man who presented for widespread itchy erythematous scaly plaques that were refractory to topical corticosteroids as well as discontinuation of possible offending medications. A biopsy demonstrated vacuolar interface dermatitis in the setting of strongly positive anti-SSA. Hydroxychloroquine treatment was effective in resolving the plaques., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2023, El Hasbani et al.)
- Published
- 2023
- Full Text
- View/download PDF
27. When Apixaban and Rivaroxaban Interfere With Anti-Xa Assays: A Cohort Study.
- Author
-
El Hasbani G, Abdelrahman M, Baker M, and Janowiecki C
- Abstract
Background: The use of direct factor Xa inhibitors, such as apixaban and rivaroxaban, has improved medication adherence. However, in certain situations during hospital admission, patients on these medications may need to be transitioned to unfractionated heparin (UFH) infusions. This transition can skew results of anticoagulation monitoring, such as the anti-Xa assay, due to residual factor-Xa inhibitor activity., Methods: We conducted this retrospective chart among admitted patients to St. Vincent's Medical Center in Bridgeport, CT between December 2020 till June 2022. Patients who were maintained on Apixaban or Rivaroxaban, factor-Xa inhibitors, and were transitioned to unfractionated intravenous drip were included. A baseline plasma anti-Xa level was noted. Assessment for thrombotic or bleeding events during hospitalization was performed., Results: A total of 48 patients were included in this study. The majority of patients were bridged to UFH for NSTEMI (31%) or pre-procedure (23%). The mean baseline anti-Xa for all patients was 0.92 U/mL. Twelve patients (25%) and one patient (2%) of patients had bleeding and thrombotic events, respectively. Although the mean baseline anti-Xa level was higher for patients who had an adverse event compared to no event, the difference was non-statistically significant. Fifty seven percent of patients who had an adverse event had a supratherapeutic plasma anti-Xa baseline level. A gastrointestinal bleed was the most common type of bleeding event., Conclusions: To prevent thrombotic or bleeding events, we suggest adopting a standard practice of obtaining a baseline anti-Xa level in patients with recent exposure to factor Xa inhibitors in order to guide the timing of UFH initiation, the dosing of heparin, and determine the need for alternative assays, such as the activated partial thromboplastin clotting time., Competing Interests: The authors have no conflicts of interest to disclose.
- Published
- 2023
- Full Text
- View/download PDF
28. Pseudomonas putida bacteremia secondary to a soft tissue wound: A case report.
- Author
-
El Hasbani G, Applewhite A, Demarais Z, Vargas J, and Mensah E
- Subjects
- Male, Humans, Aged, Anti-Bacterial Agents therapeutic use, Ceftazidime therapeutic use, Fever drug therapy, Pseudomonas putida, Bacteremia drug therapy, Bacteremia etiology
- Abstract
Pseudomonas putida is an uncommon cause of bacteremia, that usually seeds from multiple sources including soft tissues. Immunocompromised states predispose patients to fulminant infections, and sometimes death. Broad-spectrum antibiotics, such as fourth-generation cephalosporins, are usually indicated for treatment. Herein, we present a 71-year-old gentleman with fever and left leg swelling, found to have P. putida bacteremia. Intravenous (IV) ceftazidime was initiated, yielding clearance of blood cultures and clinical improvement.
- Published
- 2023
- Full Text
- View/download PDF
29. Role of pro-inflammatory interleukins in osteoarthritis: a narrative review.
- Author
-
Jrad AIS, Trad M, Bzeih W, El Hasbani G, and Uthman I
- Subjects
- Humans, Interleukins metabolism, Cytokines metabolism, Inflammation pathology, Osteoarthritis pathology, Cartilage, Articular pathology
- Abstract
Purpose: This manuscript will summarize the role of pro-inflammatory cytokines and tackle newly discussed ones within the scope of OA pathogenesis as mentioned in the recent literature. This will allow for a better understanding of the mechanisms behind such a complicated disease., Material and Methods: Relevant articles were obtained by searching key terms including "pro-inflammatory cytokines," "inflammation," "pathophysiology," "cartilage damage," and "OA" in PubMed and Google Scholar databases. The year ranges set for the selection of the articles was between 2015 -2021. Inclusion criteria was based on the relevance and contribution to the field of the study., Results: Osteoarthritis (OA) has a complex multifactorial pathophysiology which is attributed to molecular and biomechanical changes that disrupt the normal balance of synthesis and degradation of articular cartilage and subchondral bone. Pro-inflammatory cytokines, with their wide range of action and intricate signaling pathways, are the constant subject of new discoveries revolving around this inflammatory disease. The available literature indicates that some of these cytokines such as IL-33, IL-17, IL-6, and IL-22 have a direct relation to cartilage degradation, while others like IL-15, IL-1, IL-7, and IL-34 have an indirect one., Conclusions: Inflammation has an essential role in the manifestation of osteoarthritis clinical events. Specifically, certain cytokines exhibit pro-inflammatory properties that are markedly activated during the course of the disease and notably alter the homeostasis of the joint environment. However, clinical trials and observational studies remain insufficient to navigate the varying nature of this disease in humans.
- Published
- 2023
- Full Text
- View/download PDF
30. Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch.
- Author
-
El Hasbani G and Uthman I
- Subjects
- Humans, Warfarin, Antibodies, Antiphospholipid, Lupus Coagulation Inhibitor, Anticoagulants adverse effects, Antiphospholipid Syndrome complications, Lupus Erythematosus, Systemic complications, Stroke chemically induced, Thrombosis prevention & control
- Abstract
Cerebrovascular accidents (CVAs) or strokes are part of the common thrombotic manifestations of Systemic Lupus Erythematosus (SLEs) and Antiphospholipid syndrome (APS). Such neurological thrombotic events tend to occur in patients with SLE at a higher frequency when Antiphospholipid antibodies (aPLs) are present, and tend to involve the large cerebral vessels. The mechanism of stroke in SLE can be driven by complement deposition and neuroinflammation involving the blood-brain barrier although the traditional cardiovascular risk factors remain major contributing factors. Primary prevention with antiplatelet therapy and disease activity controlling agent is the basis of the management. Anticoagulation via warfarin had been a tool for secondary prevention, especially in stroke recurrence, although the debate continues regarding the target international normalized ratio (INR). The presence of either of the three criteria antiphospholipid antibodies (aPLs) and certain non-criteria aPL can be an independent risk factor for stroke. The exact mechanism for the involvement of the large cerebral arteries, especially in lupus anticoagulant (LAC) positive cases, is still to be deciphered. The data on the role of non-criteria aPL remain very limited and heterogenous, but IgA antibodies against β2GPI and the D4/5 subunit as well as aPS/PT IgG might have a contribution. Anticoagulation with warfarin has been recommended although the optimal dosing or the utility of combination with antiplatelet agents is still unknown. Minimal data is available for direct oral anticoagulants (DOACs).
- Published
- 2023
- Full Text
- View/download PDF
31. Hematological manifestations of antiphospholipid syndrome: Going beyond thrombosis.
- Author
-
El Hasbani G, Saliba AN, Uthman I, and Taher AT
- Subjects
- Humans, Antiphospholipid Syndrome complications, Antiphospholipid Syndrome diagnosis, Antiphospholipid Syndrome therapy, Thrombosis diagnosis, Thrombosis etiology, Thrombocytopenia diagnosis, Thrombocytopenia etiology, Cardiovascular Diseases, Anemia, Hemolytic, Autoimmune diagnosis, Anemia, Hemolytic, Autoimmune etiology, Anemia, Hemolytic, Autoimmune therapy
- Abstract
Thrombotic complications are a hallmark of antiphospholipid syndrome (APS). These vascular - arterial, venous, and/or small vessel - complications are well described and known to hematologists and healthcare providers caring for patients with this disease. In this review, we shed light on other hematological manifestations of the disease, including bleeding, thrombocytopenia, autoimmune hemolytic anemia, and thrombotic microangiopathy syndromes. While these manifestations are not bona fide clinical criteria for the diagnosis of APS, they frequently interact and contribute to the complexity of clinical management of APS., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
32. Erythema nodosum in Behçet's disease in remission: Think COVID-19?
- Author
-
El Hasbani G, Jawad AS, and Uthman I
- Abstract
The coronavirus disease has several manifestations related to the activation of the immune system. Because of such activation, autoimmune diseases, including vasculitis, have been reported to occur. Behçet's disease, a variable vessel vasculitis, has been discussed in the context of coronavirus disease. Rarely, the induction of Behçet's disease flare or exacerbation has been reported necessitating aggressive treatment. The presentation of Behçet's disease flares secondary to coronavirus disease is variable, including mucocutaneous lesions and eye or joint involvement. We highlight the case of a 35-year-old woman with pre-existing Behçet's disease in remission on colchicine presenting with new onset erythema nodosum-like lesions on her right shin being diagnosed with coronavirus disease infection a few days after. Despite treatment with systemic corticosteroid, the lesions did not resolve, necessitating the initiation of anti-interleukin-6 therapy., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF
33. Sarcoidosis Mimicking a Malignant Metastatic Disease.
- Author
-
El Hasbani G, El Saghir N, Moukaddam H, Farhat L, Shabb N, and Uthman I
- Abstract
Sarcoidosis can have pulmonary and extrapulmonary clinical manifestations depending on the organ of involvement. Because multiple organs are involved by the disease, sarcoid can mimic metastatic diseases. Whenever clinical and radiological clues of metastasis are present, differentials other than cancer should not be missed. Herein, we present a case of a middle aged gentleman who presented to the oncology clinic for 1-month history of low back pain associated with a dry cough along with radiological findings of metastatic disease involving the lungs, liver, lymph nodes, axial spine, and adrenal gland. A biopsy of the liver lesion showed non-caseating granuloma. Elevated blood levels of angiotensin-converting enzyme confirmed the diagnosis of sarcoidosis., Competing Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2023.)
- Published
- 2023
- Full Text
- View/download PDF
34. ANCA-Associated Vasculitis following the First Dose of Pfizer-BioNTech COVID-19 Vaccine.
- Author
-
El Hasbani G and Uthman I
- Subjects
- Female, Humans, Middle Aged, BNT162 Vaccine, COVID-19 Vaccines adverse effects, Azathioprine, COVID-19 prevention & control, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis etiology
- Abstract
Coronavirus disease (COVID-19) vaccine can alter the body's immunological balance leading to autoimmune disease in rare cases. Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is one of the autoimmune diseases which have been rarely reported to appear post-COVID-19 vaccine. Herein, we report the case of a 47-year-old woman who developed acute renal failure few days after receiving the first dose of the Pfizer-BioNTech COVID-19 vaccine. Corticosteroids along with azathioprine were used for the management., (© 2022 S. Karger AG, Basel.)
- Published
- 2023
- Full Text
- View/download PDF
35. The psychological impact of Behçet's disease.
- Author
-
El Hasbani G, Uthman I, Jawad S, and Jawad ASM
- Subjects
- Humans, Quality of Life, Behcet Syndrome complications
- Abstract
Background: Bechet's disease (BD), a chronic multiorgan involving disease, has a significant impact on quality of life in spite of effective treatment modalities. Disease manifestations such as arthritis, orogenital ulcerations, rashes, angiitis, and neurological involvement affect health-related quality of life (HRQoL) through its impact on depression, anxiety, and fatigue., Objectives: We aimed explore the psychological impact of BD, taking into consideration the effect on the HRQoL, as well as the association with depression, anxiety, wellbeing, and fatigue., Methods: This is a narrative review of the literature that looks into the association of BD on the HRQoL including all studies that have assessed such as association., Results/findings: Depression and anxiety are prevalent among patients with BD, and contribute significantly to fatigue, a common symptom among BD patients. In addition, the psychological wellbeing is affected by the disease, however, more studies are needed to assess this relationship., Conclusion: Depression and anxiety are strongly associated with BD, and contribute significantly to fatigue, a common symptom among BD patients. In addition, the psychological wellbeing is affected by the disease, however, more studies are needed to assess this relationship. Besides, the controlling factors of the psychological impact are still to be deciphered., (© 2022 John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
36. Clinical burden of hemophilia in older adults: Beyond bleeding risk.
- Author
-
Hodroj MH, El Hasbani G, Al-Shamsi HO, Samaha H, Musallam KM, and Taher AT
- Subjects
- Adult, Aged, Aging, Humans, Hemophilia A complications, Hemophilia A epidemiology, Hemophilia A therapy, Neoplasms complications
- Abstract
The prospect of hemophilia patients has dramatically improved in the last few decades with the introduction of various interventions that can effectively treat or prevent their bleeding risk. The life expectancy of patients can now reach that of the healthy population, but this has paved the way for several previously unrecognized morbidities to manifest in older adults with hemophilia. Such clinical complications are attributed to suboptimal management or poor access to effective therapy during childhood as well as chronicity and prolonged exposure to the underlying pathophysiology of the disease and its treatment. Complications common in the aging population are also becoming increasingly relevant in this vulnerable patient subgroup. In this review, we highlight peculiarities of such morbidities including chronic viral infections and liver disease, debilitating joint impairment and bone disease, cardiovascular and chronic kidney disease, and cancers. We also reflect on topics of special interest in adulthood such as sexuality., (Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
37. SARS-CoV-2 historical global testing and genomic variability.
- Author
-
Tannous H, Akiki S, E Boulos R, El Khoury Eid C, El Hasbani G, Khoueiry LM, El Khoury L, Tohme R, Moussa R, and Khazen G
- Subjects
- Disease Outbreaks, Genome, Viral, Genomics, Humans, COVID-19 epidemiology, SARS-CoV-2 genetics
- Abstract
The world has been dealing with the SARS-COV-2 pandemic since December 2019 and a lot of effort has focused on tracking the spread of the virus by gathering information regarding testing statistics and generating viral genomic sequences. Unfortunately, there is neither a single comprehensive resource with global historical testing data nor a centralized database with summary statistics of the identified genomic variants. We merged different pre-aggregated historical testing data and complemented them with our manually extracted ones, which consist of 6852 historical test statistics from 76 countries/states unreported in any other dataset, at the date of submission, making our dataset the most comprehensive to date. We also analyzed all publicly deposited SARS-CoV-2 genomic sequences in GISAID and annotated their variants. Both datasets can be accessed through our interactive dashboard which also provides important insights on different outbreak trends across countries and states. The dashboard is available at https://bioinfo.lau.edu.lb/gkhazen/covid19 . A daily updated version of the datasets can be downloaded from github.com/KhazenLab/covid19-data., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
38. Rheumatoid Cerebral Vasculitis in a Patient in Remission.
- Author
-
El Hasbani G, El Ouweini H, Dabdoub F, Hourani R, Jawad AS, and Uthman I
- Abstract
Cerebral vasculitis is a very rare extra-articular complication of rheumatoid arthritis (RA) that is often challenging to diagnose. Elevated titers of rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), and antinuclear antibodies (ANA) have been linked with severe complications. The absence of highly elevated titers of RF, anti-CCP, and ANA can complicate the diagnosis of RA-associated cerebral vasculitis. We report the case of a 59-year-old woman with long-standing arthritis maintained on rituximab and leflunomide who developed sudden headaches and altered level of consciousness. Laboratory work-up revealed normal lymphocyte count and mildly elevated total serum protein and anti-CCP with negative RF and ANA and no evidence for viral or bacterial infections. Cerebrospinal fluid analysis (CSF) showed slightly elevated anti-CCP with normal levels of CXCL-13 and interleukin 6 (IL-6). Brain magnetic resonance imaging (MRI) showed ill-defined lesion of high T2 signal. Using MR angiogram, MR perfusion, and MR spectroscopy, the diagnosis of rheumatoid cerebral vasculitis was confirmed. The patient was treated with intravenous methyl-prednisolone with fast complete improvement. We conclude that adequate immunosuppression in RA might not be able to prevent rare extra-articular manifestations such as rheumatoid cerebral vasculitis., Competing Interests: Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
39. Thalassemia and autoimmune diseases: Absence of evidence or evidence of absence?
- Author
-
El Hasbani G, Musallam KM, Uthman I, Cappellini MD, and Taher AT
- Subjects
- Carrier State epidemiology, Comorbidity, Humans, Thalassemia therapy, beta-Thalassemia epidemiology, Autoimmune Diseases epidemiology, Thalassemia epidemiology
- Abstract
The thalassemias are a group of inherited disorders of hemoglobin synthesis that continue to pause a global public health concern. The complex molecular and pathogenetic pathways involved in disease process lead to an array of comorbidities that require lifelong management. The disease and its treatment can also lead to alterations in immune function and a link to various autoimmune diseases has been frequently suggested. However, most data stem from single case reports and small studies that do not allow proper assessment of causal associations. Still, the high morbidity in thalassemia makes patients vulnerable to the added burden of coexisting autoimmune diseases, and special management considerations in this patient population are warranted. In this review, we explore insights and data from the literature on various autoimmune disease that have been observed in patients with thalassemia. The role of the thalassemia carrier state in modifying outcomes of patients with autoimmune diseases is also discussed., (Copyright © 2021. Published by Elsevier Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
40. The effect of wet-cupping therapy (hijama) in modulating autoimmune activity of Hashimoto's thyroiditis.: A pilot controlled study.
- Author
-
Jawad AS, El-Hasbani G, and Uthman I
- Subjects
- Humans, Pilot Projects, Cupping Therapy, Hashimoto Disease therapy, Thyroiditis, Autoimmune
- Published
- 2022
- Full Text
- View/download PDF
41. Trigger Finger Induced by Growth Hormone Supplements in a Muscular Man.
- Author
-
El Hasbani G, Khoury NJ, and Uthman I
- Subjects
- Growth Hormone, Humans, Male, Musculoskeletal System, Trigger Finger Disorder
- Abstract
Competing Interests: The authors declare no conflict of interest.
- Published
- 2021
- Full Text
- View/download PDF
42. COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
- Author
-
Wang X, Gkrouzman E, Andrade DCO, Andreoli L, Barbhaiya M, Belmont HM, Branch DW, de Jesús GR, Efthymiou M, Ríos-Garcés R, Gerosa M, El Hasbani G, Knight J, Meroni PL, Pazzola G, Petri M, Rand J, Salmon J, Tektonidou M, Tincani A, Uthman IW, Zuily S, Zuo Y, Lockshin M, Cohen H, and Erkan D
- Subjects
- Humans, Antibodies, Antiphospholipid, Antiphospholipid Syndrome, COVID-19 pathology, Thrombosis virology
- Abstract
Coronavirus disease 2019 (COVID-19) is associated with a high rate of thrombosis. Prolonged activated partial thromboplastin times (aPTT) and antiphospholipid antibodies (aPL) are reported in COVID-19 patients. The majority of publications have not reported whether patients develop clinically relevant persistent aPL, and the clinical significance of new aPL-positivity in COVID-19 is currently unknown. However, the reports of aPL-positivity in COVID-19 raised the question whether common mechanisms exist in the pathogenesis of COVID-19 and antiphospholipid syndrome (APS). In both conditions, thrombotic microangiopathy resulting in microvascular injury and thrombosis is hypothesized to occur through multiple pathways, including endothelial damage, complement activation, and release of neutrophil extracellular traps (NETosis). APS-ACTION, an international APS research network, created a COVID-19 working group that reviewed common mechanisms, positive aPL tests in COVID-19 patients, and implications of COVID-19 infection for patients with known aPL positivity or APS, with the goals of proposing guidance for clinical management and monitoring of aPL-positive COVID-19 patients. This guidance also serves as a call and focus for clinical and basic scientific research.
- Published
- 2021
- Full Text
- View/download PDF
43. Henoch-Schönlein purpura: Another COVID-19 complication.
- Author
-
El Hasbani G, Taher AT, Jawad ASM, and Uthman I
- Subjects
- Adolescent, Child, Humans, Male, Pain, Prednisolone therapeutic use, SARS-CoV-2, COVID-19, IgA Vasculitis complications, IgA Vasculitis diagnosis, IgA Vasculitis drug therapy
- Abstract
Whether affecting children or adults, SARS-CoV-2 infection (COVID-19) can have multi-organ involvement mediated by an inflammatory cascade. Immunoglobulin A (IgA) is one of the key components of the inflammatory cascade that can lead to endothelial injury and inflammation. IgA vasculitis or Henoch-Schönlein purpura (HSP) has been rarely reported in the context of COVID-19. In this report, we highlight a case of HSP occurring 2 days after diagnosis of COVID-19 in a 16-year-old boy, who presented with palpable purpura of the lower extremities and buttocks, diffuse abdominal pain, hemoptysis, and hematochezia. He was treated with oral prednisolone with rapid clinical improvement., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
44. I drank too much and now I can't walk: a case of alcohol-induced dysautonomia.
- Author
-
Assaker R, El Hasbani G, Antezana AA, Gamarra JV, Amaya-Suarez J, Bertely C, and Suleman N
- Abstract
Dysautonomia is a dysfunction of the autonomic nervous system, which mediates both sympathetic and parasympathetic functions of the human body. Alcohol has been established to affect the autonomic function through liver injury and accumulation of vasodilators. Alcohol can induce peripheral neurological diseases as well. This case report describes a patient who had a chronic history of alcoholism and uncontrolled diabetes mellitus presenting for orthostatic hypotension and peripheral neuropathy without underlying liver disease or other endocrinopathies. Although diabetes mellitus was controlled pharmacologically and risk factors for orthostatic hypotension were managed conservatively, his symptoms did not improve which indicated an alcohol-related autonomic dysfunction, shedding light on one of long-term complications of alcoholism., (© The Author(s) 2021. Published by Oxford University Press.)
- Published
- 2021
- Full Text
- View/download PDF
45. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?
- Author
-
El Hasbani G and Taher AT
- Subjects
- Anticoagulants therapeutic use, Humans, SARS-CoV-2, COVID-19, Thrombophilia complications, Thrombosis
- Abstract
The inflammatory component of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) creates a pro-thrombotic state that necessitates a thrombophylactic strategy for hospitalized patients. Such strategies are difficult to be standardized because certain individuals can have pro-thrombotic conditions, such as inherited thrombophilia, which pre-dispose them to an additional coagulative risk. Whether outside the hospital or when admitted, patients with inherited thrombophilia need special anticoagulant and antiplatelet attention. Identifying such patients, especially in susceptible populations like the eastern Mediterranean (EM) region, will aid primary providers in risk stratification for choosing the optimal anticoagulation or antiplatelet plan., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
46. Characterizing the presence of neutrophil extracellular traps in neutrophilic dermatoses.
- Author
-
Eid E, Safi R, El Hasbani G, Aftimos V, Abbas O, Kibbi AG, and Nassar D
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Male, Middle Aged, Pyoderma Gangrenosum pathology, Sweet Syndrome pathology, Young Adult, Extracellular Traps, Neutrophils pathology, Skin Diseases, Vesiculobullous pathology
- Abstract
Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of multiple inflammatory dermatoses. However, characterization of NETs in neutrophilic dermatoses was performed on very limited number of patients; this limitation precluded definitive conclusions. In this case series of 57 patients, we compared the amounts of neutrophils producing NETs in cutaneous lesions of different entities of neutrophilic dermatoses (17 with pyoderma gangrenosum, 37 with Sweet's syndrome and three with subcorneal pustular dermatosis). NETs were identified by double immunofluorescence on formalin-fixed paraffin-embedded skin biopsies using antibodies against elastase and citrullinated histone 3. Percentages of neutrophils showing NETs were high across all three entities (62.9% in PG, 48.5% in SS and 37.8% in subcorneal pustular dermatosis). The differences in mean percentages were significant between entities, with PG showing significantly superior percentage of NETs compared with SS. In our series, 15.8% of neutrophilic dermatoses were associated with malignancies, 10.5% with autoimmune diseases and 73.7% were idiopathic. Percentages of NETs were not statistically different between aetiologies. These findings suggest that NETs are abundantly produced in the various entities and different aetiologies of neutrophilic dermatoses. In comparison with SS, the superior percentage of NETs in PG is clinically mirrored in its greater ulceronecrotic nature., (© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
47. Complex vesicocutaneous fistula: Successful conservative management.
- Author
-
Assaker R, El Hasbani G, Amoateng D, Vargas J, Nepal P, and Armm M
- Abstract
Vesicocutaneous fistulas are rare entities that could be either congenital or acquired. The diagnosis is usually based on clinical findings and imaging modalities. While most vesicocutaneous fistulas heal spontaneously, it is important to decrease the intravesicular pressure by diverting the urine. Moreover, surgical options are present to remove the fistula. In this case report, we highlight the case of a 67-year-old male, with recurrent obstructive cystitis and colorectal adenocarcinoma who developed a vesicocutaneous fistula. Decompression of the bladder led to complete closure of the tract., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
48. Investigating the presence of neutrophil extracellular traps in septal and lobular cutaneous panniculitides.
- Author
-
Safi R, El Hasbani G, Bardawil T, Abbas O, Kibbi AG, and Nassar D
- Subjects
- Humans, Skin, Erythema Nodosum, Extracellular Traps, Panniculitis, Panniculitis, Lupus Erythematosus
- Abstract
Background: Panniculitides are a heterogeneous group of inflammatory dermatoses involving the subcutaneous fatty tissue. Histologically, they are classified into septal and lobular panniculitis, according to the predominant localization of the inflammatory infiltrate. Neutrophils are frequently found in panniculitis, mainly at the early stages. Here, we investigated whether neutrophils contribute to various types of cutaneous panniculitis by releasing neutrophil extracellular traps (NETs)., Materials and Methods: Formalin-fixed paraffin-embedded skin biopsies from 25 patients with panniculitis were included in the study. Our cohort was divided into n = 10 erythema nodosum (septal panniculitis) and n = 15 lobular panniculitis, including n = 7 lupus panniculitis, n = 1 pancreatic panniculitis, n = 1 Weber-Christian disease, n = 1 deep fungal infection, n = 2 lipodermatosclerosis, and three cases did not have an identified etiology. The presence of neutrophils and NETs was assessed by double immunofluorescence using antibodies against elastase, a neutrophilic marker, and citrullinated histone 3, a marker of NETs., Results: The mean percentages (±SEM) of elastase-positive neutrophils showing NETs were 44% ± 3% in erythema nodosum and 43% ± 7% in lobular panniculitis. The difference was not statistically significant and reflects the implication of NETs not only in severe scarring lobular panniculitis but also in benign non-scarring self-remitting reactive inflammation such as erythema nodosum. In tissues, NETs were located in the interlobular septa in erythema nodosum and in the inflamed fat lobules in lobular panniculitis., Conclusions: NETs are massively present in septal and lobular subtypes of panniculitides, suggesting their involvement in tissue damage., (© 2021 the International Society of Dermatology.)
- Published
- 2021
- Full Text
- View/download PDF
49. Polymyalgia rheumatica-like presentation in a case of diffuse large B-cell lymphoma: a diagnostic pitfall.
- Author
-
El Hasbani G, Taher AT, Abi-Ghanem AS, Nassif S, Bizri AR, and Uthman I
- Subjects
- Biopsy, Female, Humans, Middle Aged, Positron Emission Tomography Computed Tomography, Giant Cell Arteritis, Lymphoma, Large B-Cell, Diffuse diagnostic imaging, Lymphoma, Large B-Cell, Diffuse drug therapy, Polymyalgia Rheumatica diagnosis, Polymyalgia Rheumatica drug therapy
- Abstract
Diffuse large B-cell lymphoma (DLBCL) commonly presents with systemic manifestations including fever, weight loss, and night sweats. Uncommonly, patients with DLBCL can present with musculoskeletal manifestations mimicking polymyalgia rheumatica (PMR). Herein, the case of a 61-year-old woman who presented with pain in the bilateral shoulders, arms, hands, knees, pelvic girdle, and neck with bouts of fever, is presented. Laboratory workup for infectious and connective tissue diseases was non-revealing, except for elevated inflammatory markers. A positron emission tomography (PET)/computed tomography (CT) scan was suggestive of PMR, but also revealed enlarged lymph nodes initially thought to be reactive in nature. However, a lymph node biopsy showed findings consistent with DLBCL. This case highlights the importance of a thorough investigational workup when cases with features of PMR do not meet the proper criteria for this diagnosis to be made, in order not to miss a hematopoietic neoplasm with a PMR-like presentation.
- Published
- 2021
- Full Text
- View/download PDF
50. Antiphospholipid syndrome: the need for new international classification criteria.
- Author
-
El Hasbani G, Taher AT, Sciascia S, and Uthman I
- Subjects
- Antibodies, Antiphospholipid, Databases, Factual, Female, Humans, Lupus Coagulation Inhibitor, Pregnancy, Antiphospholipid Syndrome diagnosis, Thrombosis
- Abstract
Introduction : As soon as the association of lupus anticoagulant (LAC) and anticardiolipin antibodies (aCL) with thrombosis and miscarriages was described in the 1980s, the definition of the antiphospholipid syndrome (APS) became a need. Early descriptions of the disease by members of the Graham Hughes team included broad categories and unexplained laboratory inclusions. Over time, new clinical and experimental data refined the criteria, especially the obstetric manifestations, as well as the laboratory criteria. Areas covered : The authors performed a review of the literature using the PubMed database, and the following keywords were used: 'antiphospholipid antibody', 'antiphospholipid syndrome', and 'criteria of antiphospholipid'. The history of antiphospholipid criteria, clinical and experimental advancements, and other expert opinions were included in this paper. Expert opinion : It has been 14 years since an international congress on antiphospholipid antibodies has generated new classification based on the recent extensive research performed in the field. Currently, there is a need to update the international APS classification taking into consideration the inclusion of new clinical criteria such as aPL-related nephropathy as well as new standardized antibody specificities (e.g., anti-phosphatidylserine/prothrombin antibodies) with the adoption of a standardized scoring system that can stratify APS patients.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.